AVE5026
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for AVE5026, covering 2013-01-23 to 2016-05-03. Get the full timeline:
Most recent: Clinical Trial Update: Study of AVE5026 at Weight-adjusted Doses in Children With a Central Venous Line [Phase 2]